Literature DB >> 9176271

Temporary acidosis during reperfusion limits myocardial infarct size in dogs.

M Kitakaze1, S Takashima, H Funaya, T Minamino, K Node, Y Shinozaki, H Mori, M Hori.   

Abstract

We tested the hypothesis that myocardial extracellular acidosis during early reperfusion limits infarct size. The left anterior descending coronary artery was perfused with blood through a bypass tube in dogs. We occluded the bypass tube for 40 (protocol I; n = 24 hearts) and 90 min (protocol II; n = 36 hearts). In protocols I and II, we infused one group of hearts with HCl (60 micrograms.kg-1.min-1) for 60 min after the onset of reperfusion (the metabolic acidosis group), and another group of hearts were ventilated with 3 liters of 70% O2-30% CO2 mixed with room air 10 min before the onset of reperfusion for 70 min (the respiratory acidosis group). pH in the coronary venous blood and myocardial pH during reperfusion in the metabolic and respiratory acidosis groups were lower than those in the control groups. Infarct sizes in the metabolic (16.4 +/- 2.5 and 22.3 +/- 2.5%) and respiratory (16.7 +/- 2.6 and 22.3 +/- 2.5%) acidosis groups in protocols I and II, respectively, were smaller than those in the control groups (33.1 +/- 3.0 and 40.6 +/- 4.1%, respectively). Thus we conclude that temporary acidosis during reperfusion limits infarct size.

Entities:  

Mesh:

Year:  1997        PMID: 9176271     DOI: 10.1152/ajpheart.1997.272.5.H2071

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

Review 1.  Permissive hypercapnia--role in protective lung ventilatory strategies.

Authors:  John G Laffey; Donall O'Croinin; Paul McLoughlin; Brian P Kavanagh
Journal:  Intensive Care Med       Date:  2004-01-14       Impact factor: 17.440

Review 2.  Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?

Authors:  Sabzali Javadov; Sehwan Jang; Rebecca Parodi-Rullán; Zaza Khuchua; Andrey V Kuznetsov
Journal:  Cell Mol Life Sci       Date:  2017-04-04       Impact factor: 9.261

Review 3.  Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.

Authors:  Demetria M Fischesser; Bin Bo; Rachel P Benton; Haili Su; Newsha Jahanpanah; Kevin J Haworth
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-17       Impact factor: 2.457

Review 4.  Bench-to-bedside review: carbon dioxide.

Authors:  Gerard Curley; John G Laffey; Brian P Kavanagh
Journal:  Crit Care       Date:  2010-04-30       Impact factor: 9.097

Review 5.  Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.

Authors:  José Lillo-Moya; Catalina Rojas-Solé; Diego Muñoz-Salamanca; Emiliano Panieri; Luciano Saso; Ramón Rodrigo
Journal:  Antioxidants (Basel)       Date:  2021-04-25

6.  NHE inhibition does not improve Na(+) or Ca(2+) overload during reperfusion: using modeling to illuminate the mechanisms underlying a therapeutic failure.

Authors:  Byron N Roberts; David J Christini
Journal:  PLoS Comput Biol       Date:  2011-10-20       Impact factor: 4.475

Review 7.  Bench-to-bedside review: hypercapnic acidosis in lung injury--from 'permissive' to 'therapeutic'.

Authors:  Marloes M Ijland; Leo M Heunks; Johannes G van der Hoeven
Journal:  Crit Care       Date:  2010-11-03       Impact factor: 9.097

Review 8.  Bench-to-bedside review: Permissive hypercapnia.

Authors:  Donall O'Croinin; Martina Ni Chonghaile; Brendan Higgins; John G Laffey
Journal:  Crit Care       Date:  2004-08-05       Impact factor: 9.097

Review 9.  Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit - the role of buffers.

Authors:  Brian K Gehlbach; Gregory A Schmidt
Journal:  Crit Care       Date:  2004-05-05       Impact factor: 9.097

10.  Effects of resuscitation with crystalloid fluids on cardiac function in patients with severe sepsis.

Authors:  Zhi Xun Fang; Yu Feng Li; Xiao Qing Zhou; Zhen Zhang; Jin Song Zhang; Hai Ming Xia; Guo Ping Xing; Wei Ping Shu; Ling Shen; Guo Qing Yin
Journal:  BMC Infect Dis       Date:  2008-04-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.